Deregulated Akt3 activity promotes development of malignant melanoma. - Wikidata - wikimedia - TriplyDB

Deregulated Akt3 activity promotes development of malignant melanoma.

Deregulated Akt3 activity promotes development of malignant melanoma.

http://www.wikidata.org/entity/Q34355872

about

Main roads to melanoma Melanoma: from melanocyte to genetic alterations and clinical options Analysis of the genome to personalize therapy for melanoma The mTOR signalling pathway in human cancer Therapeutic Implications of Targeting AKT Signaling in Melanoma Melanoma: oncogenic drivers and the immune system Current State of Animal (Mouse) Modeling in Melanoma Research Therapy for BRAFi-Resistant Melanomas: Is WNT5A the Answer?The GIST of targeted therapy for malignant melanoma Emerging targeted therapies for melanoma treatment (review)Diverse mechanisms of AKT pathway activation in human malignancy Pathways and therapeutic targets in melanoma Beyond BRAF: where next for melanoma therapy?Emerging phytochemicals for prevention of melanoma invasion Melanoma: from mutations to medicine Structure-Based Design of an Organoruthenium Phosphatidyl-inositol-3-kinase Inhibitor Reveals a Switch Governing Lipid Kinase Potency and Selectivity Reversing melanoma cross-resistance to BRAF and MEK inhibitors by co-targeting the AKT/mTOR pathway.Targeting TBK1 inhibits migration and resistance to MEK inhibitors in mutant NRAS melanoma.Melanoma Brain Metastasis: Mechanisms, Models, and Medicine Will targeting PI3K/Akt/mTOR signaling work in hematopoietic malignancies?Mutant B-RAF signaling and cyclin D1 regulate Cks1/S-phase kinase-associated protein 2-mediated degradation of p27Kip1 in human melanoma cells Oncogenic mutations of PIK3CA in human cancers A proteomics approach to identifying key protein targets involved in VEGF inhibitor mediated attenuation of bleomycin-induced pulmonary fibrosis The role of T‑box genes in the tumorigenesis and progression of cancer (Review)Irradiated riboflavin diminishes the aggressiveness of melanoma in vitro and in vivo A melanoma molecular disease model Regulation of PI3K effector signalling in cancer by the phosphoinositide phosphatases MicroRNA-207 enhances radiation-induced apoptosis by directly targeting Akt3 in cochlea hair cells.Clinical activity and safety of combination therapy with temsirolimus and bevacizumab for advanced melanoma: a phase II trial (CTEP 7190/Mel47)MicroRNAs induced in melanoma treated with combination targeted therapy of Temsirolimus and Bevacizumab Akt3 is responsible for the survival and proliferation of embryonic stem cells Identification of diagnostic markers in colorectal cancer via integrative epigenomics and genomics data A functional screen identifies specific microRNAs capable of inhibiting human melanoma cell viability.Targeting Akt3 signaling in malignant melanoma using isoselenocyanates.Induction of thyroid gene expression and radioiodine uptake in melanoma cells: novel therapeutic implications.Identification of glycogen synthase kinase 3α as a therapeutic target in melanoma AKT2 is a downstream target of metabotropic glutamate receptor 1 (Grm1).Timp1 Promotes Cell Survival by Activating the PDK1 Signaling Pathway in Melanoma.Molecular pathogenesis of sporadic melanoma and melanoma-initiating cells.Melanoma genetics and the development of rational therapeutics.

P2860

Q21245465-42BA60E3-EE39-4B85-9157-D5C5B68F363B Q21284811-C9A46EB5-D57D-4AA6-AE09-37E9DD5FF75D Q24601008-9877716E-0486-4BB7-963A-3974879A2EE9 Q24627306-9A2FAFF2-714C-4195-9EC3-05D4C75685EB Q24631438-D83BF234-C46D-40B8-9294-411C65CFBAD6 Q26775598-1D3DED3A-4DF5-446F-BBF9-473563EE8D6A Q26781652-37CF1E66-84CF-42B1-8004-AEF0A8AD356E Q26782222-559FDF2B-002D-4F0A-ADC9-2F696ECAC651 Q26827092-20F55776-9D84-460E-B682-07CCF14DF0C1 Q26829997-C5BCBADD-6929-4A4A-8D0C-4F19F7C8675C Q26851604-1E8D6C77-0A87-448E-B093-DA1AC9991CA7 Q26865736-DF6D5323-5B5C-40FA-99DD-0F5B9AE92353 Q27006853-DC537549-FBF1-4151-B54A-1B0D67BB8857 Q27023283-BDDD4F96-A91A-4CB0-97AF-566B653872EE Q27024061-62A0E819-CC51-4609-AE24-489472C735DB Q27650628-D866EBB3-F5C4-4886-971B-A8198ED6B201 Q27851698-A3DBAF98-D578-4E7F-A7B7-C0E0ADF3E384 Q27853026-0F97499D-239F-4FA5-ADF1-80BDC41FA6CF Q28069421-5379E8E8-C7C7-4652-A4DF-FEE6020E9553 Q28078957-2C67D4EE-454E-429C-B229-C5B7753EC019 Q28259285-350B627F-97E3-4009-A0A9-4CEC132A8B7E Q28284802-D79FEF3C-5F43-4FE5-98F9-9B76B0117A21 Q28383207-2A83C84D-3E74-4DFC-9D36-6FD68B6B8C02 Q28468370-6F56A8CA-3220-49BF-B92D-E6A76BF699F9 Q28485143-1573FE9B-E02C-4590-89AA-0CCFC0FAF0E2 Q28741507-7F4E326A-5125-4B16-9A57-FB7136ABE855 Q29248612-C04B2ECA-A026-4179-94A7-02B0FC1D2921 Q30397117-F64CEAB8-B537-413A-8007-4C1C9838A3F1 Q30412106-3BC27449-7AD0-4B9E-8B22-46256D7318E8 Q30415894-027AB6DF-B074-497E-B714-722171FF4DB9 Q30491624-DD200073-66EB-4A2C-9CC6-A9B6A05D314B Q30956148-B449747F-FC04-4275-9633-72C77DC92471 Q31087541-E94C2B51-DE7C-4FAE-804F-EAEF269B67A5 Q33408109-74BC08C7-E591-4AB5-8A21-CA3DD745D77F Q33480990-4F1BC6A1-2961-440D-893A-08B86F7919BD Q33569998-404A43C3-95F5-4C80-B414-DF05F552992A Q33605016-F8E7B9DF-1AC7-42D6-9773-FC7D8175CB67 Q33607957-00221F4A-B742-4AF0-B3B4-4CECD5CBF56A Q33725172-9B6CF5B8-2B11-4EA6-992B-E1A2D3E1FF1D Q33726956-283BB2F0-1E10-47BC-9527-A99AA7E1CB4B

P2860

Deregulated Akt3 activity promotes development of malignant melanoma.

http://www.wikidata.org/entity/Q34355872

description

2004 nî lūn-bûn

@nan

2004 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2004 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2004年の論文

@ja

2004年論文

@yue

2004年論文

@zh-hant

2004年論文

@zh-hk

2004年論文

@zh-mo

2004年論文

@zh-tw

2004年论文

@wuu

name

Deregulated Akt3 activity promotes development of malignant melanoma.

@ast

Deregulated Akt3 activity promotes development of malignant melanoma.

@en

Deregulated Akt3 activity promotes development of malignant melanoma.

@nl

type

label

Deregulated Akt3 activity promotes development of malignant melanoma.

@ast

Deregulated Akt3 activity promotes development of malignant melanoma.

@en

Deregulated Akt3 activity promotes development of malignant melanoma.

@nl

prefLabel

Deregulated Akt3 activity promotes development of malignant melanoma.

@ast

Deregulated Akt3 activity promotes development of malignant melanoma.

@en

Deregulated Akt3 activity promotes development of malignant melanoma.

@nl

P1433

Q34355872-5467D09B-2F90-46CC-BA34-4CE7D2C0F904

P1476

Q34355872-63E9B921-74AC-49A6-917D-E15012613029

P2093

Q34355872-1E088991-DA21-4A79-B89F-16AEB92C9563

Q34355872-25292873-01F1-474A-A483-E321588BEEE4

Q34355872-3FA3C1C4-F9DC-4A44-A629-008E75F5F0F5

Q34355872-46D2C248-695B-4235-89DE-329AF275A0F8

Q34355872-6E2BFACA-D1B7-41B8-A629-629758D47612

Q34355872-800E1762-AD7C-44E8-9FBE-042DB9B007E7

Q34355872-83A91B47-CB77-4B0F-97C0-E5A4475352FE

Q34355872-ADFBBA4C-BE24-43F0-8880-9A4BF7D1B0D8

P304

Q34355872-80D18F5B-4843-445E-8D15-E1397F2F6058

P31

Q34355872-7CF078FD-9D62-4054-A1F2-F386E3FC6B14

P356

Q34355872-A65DAF8C-648C-4629-B170-BC19652E8FE5

P407

Q34355872-76CB254B-17BF-4C5E-B8E1-FB337970B395

P433

Q34355872-AEE88B07-F21E-4B68-822B-597E328E2B29

P478

Q34355872-192E1C5E-DAA0-4774-B5C8-974852595878

P50

Q34355872-818E5D81-A311-4322-B53F-30D0D08AE05F

P577

Q34355872-C590205C-C2B2-44BA-9598-2B61F67A80B6

P698

Q34355872-868FCE9A-B3E0-4C57-B2B4-B6A01AA7E562

P356

0008-5472.CAN-04-1399

P1433

Cancer Research

P1476

Deregulated Akt3 activity promotes development of malignant melanoma.

@en

P2093

Arati Sharma

http://www.w3.org/2001/XMLSchema#string

Gavin P Robertson

http://www.w3.org/2001/XMLSchema#string

Jill M Stahl

http://www.w3.org/2001/XMLSchema#string

Jin Q Cheng

http://www.w3.org/2001/XMLSchema#string

Lakshman Sandirasegarane

http://www.w3.org/2001/XMLSchema#string

Marcus W Bosenberg

http://www.w3.org/2001/XMLSchema#string

Melissa Zimmerman

http://www.w3.org/2001/XMLSchema#string

Mitchell Cheung

http://www.w3.org/2001/XMLSchema#string

P304

7002-7010

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1158/0008-5472.CAN-04-1399

http://www.w3.org/2001/XMLSchema#string

P407

P433

19

http://www.w3.org/2001/XMLSchema#string

P478

64

http://www.w3.org/2001/XMLSchema#string

P50

P577

2004-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

15466193

http://www.w3.org/2001/XMLSchema#string